Tickers — C

177 tickers
Ranks this page's recent reports by score.
CVR Energy, Inc.
CVI·Energy
D ★Strong Sell
Current$58.37
Oct 31, 2026

CVR Energy offers meaningful cyclical earnings recovery potential through refining and fertilizer operations, but elevated historical valuation and volatile cash flows create substantial downside if commodity margins weaken.

Score
47
The Vita Coco Company, Inc.
COCO·Consumer Staples
B ★★★Hold
Current$58.48
Target$63.45
Return+8.5%
Oct 31, 2026

Vita Coco combines leading coconut water brand equity, strong organic demand, and expanding global distribution, but acquisition-driven growth and volatile input costs create uncertainty around sustainable margins and valuation.

Score
71
Constellium SE
CSTM·Materials
A ★★★★Buy
Current$23.11
Target$30.59
Return+32.4%
Oct 31, 2026

Constellium offers upside from aerospace recovery, stronger cash flow, and improving leverage at an attractive valuation, but cyclical demand and metal-price-driven earnings volatility could limit sustainable profitability.

Score
78
Concentra Group Holdings Parent, Inc.
CON·Healthcare
B ★★★Hold
Current$40.38
Target$41.00
Return+1.5%
Oct 31, 2026

Concentra's national occupational healthcare network and improving cash generation support durable earnings growth, but elevated valuation multiples and acquisition-related leverage constrain prospective returns.

Score
69
Churchill Downs Incorporated
CHDN·Consumer Discretionary
A ★★★★Buy
Current$94.83
Target$112.50
Return+18.6%
Oct 31, 2026

Churchill Downs combines a premium Kentucky Derby franchise and profitable historical racing assets with attractive valuation and potential deleveraging, although significant debt and uncertain casino divestment economics remain key risks.

Score
77
Core Scientific, Inc.
CORZ·Technology
C ★★Sell
Current$13.25
Oct 31, 2026

Core Scientific could become a major contracted AI data-center infrastructure provider through rapid power-capacity activation, but heavy construction spending, debt, and uncertain free cash flow threaten equity returns.

Score
59
Corcept Therapeutics Incorporated
CORT·Healthcare
B ★★★Hold
Current$81.12
Target$96.00
Return+18.3%
Oct 31, 2026

Corcept's expanding oncology franchise and proprietary cortisol-modulation pipeline could drive sustained pharmaceutical growth, but regulatory uncertainty and demanding cash-flow valuation constrain the near-term investment opportunity.

Score
68
Cenovus Energy Inc.
CVE·Energy
B ★★★Hold
Current$32.73
Target$35.03
Return+7.0%
Oct 31, 2026

Cenovus offers strong oil sands cash generation, operational scale, and acquisition-led production growth, but its elevated historical valuation and exposure to crude prices and integration risks limit near-term upside.

Score
67
Coinbase Global, Inc.
COIN·Financials
C ★★Sell
Current$143.54
Oct 31, 2026

Coinbase could become a diversified digital-finance platform through trading, stablecoins, and derivatives, but weakening transaction revenue and volatile recurring earnings make its current valuation difficult to justify.

Score
58
Canadian Pacific Kansas City Limited
CP·Industrials
B ★★★Hold
Current$89.68
Target$96.60
Return+7.7%
Oct 31, 2026

CPKC's unique Canada-U.S.-Mexico railway network offers durable competitive advantages and long-term freight growth, but premium cash-flow expectations and persistent capital intensity limit its margin of safety.

Score
71
C.H. Robinson Worldwide, Inc.
CHRW·Industrials
B ★★★Hold
Current$124.61
Target$140.00
Return+12.4%
Oct 31, 2026

C.H. Robinson's large asset-light logistics network and AI-driven productivity improvements support long-term earnings growth, but RXO acquisition risk, litigation exposure, and weak cash conversion limit investment conviction.

Score
66
Calix, Inc.
CALX·Technology
B ★★★Hold
Current$36.82
Target$46.00
Return+24.9%
Oct 31, 2026

Calix can compound value through broadband platform adoption, expanding managed services, and improving operating leverage, but hardware dependence, component inflation, and shareholder dilution limit the certainty of sustained earnings growth.

Score
71